Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Mar;52(3):927-36.
doi: 10.1128/AAC.01223-07. Epub 2008 Jan 7.

Increase of virulence and its phenotypic traits in drug-resistant strains of Candida albicans

Affiliations

Increase of virulence and its phenotypic traits in drug-resistant strains of Candida albicans

Letizia Angiolella et al. Antimicrob Agents Chemother. 2008 Mar.

Abstract

There is concern about the rise of antifungal drug resistance, but little is known about comparative biological properties and pathogenicity of drug-resistant strains. We generated fluconazole (FLC; CO23 RFLC)- or micafungin (FK; CO23 RFK)-resistant strains of Candida albicans by treating a FLC- and FK-susceptible strain of this fungus (CO23 S) with stepwise-increasing concentrations of either drug. Molecular analyses showed that CO23 RFLC had acquired markedly increased expression of the drug-resistance efflux pump encoded by the MDR1 gene, whereas CO23 RFK had a homozygous mutation in the FSK1 gene. These genetic modifications did not alter to any extent the growth capacity of the drug-resistant strains in vitro, either at 28 degrees C or at 37 degrees C, but markedly increased their experimental pathogenicity in a systemic mouse infection model, as assessed by the overall mortality and target organ invasion. Interestingly, no apparent increase in the vaginopathic potential of the strains was observed with an estrogen-dependent rat vaginal infection. The increased pathogenicity of drug-resistant strains for systemic infection was associated with a number of biochemical and physiological changes, including (i) marked cellular alterations associated with a different expression and content of major cell wall polysaccharides, (ii) more rapid and extensive hypha formation in both liquid and solid media, and (iii) increased adherence to plastic and a propensity for biofilm formation. Overall, our data demonstrate that experimentally induced resistance to antifungal drugs, irrespective of drug family, can substantially divert C. albicans biology, affecting in particular biological properties of potential relevance for deep-seated candidiasis.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Growth curves (A), scanning electron micrographs (EM) (B), and cell volume (C) of CO23S (wild-type strain) and CO23RFK and CO23RFLC (FK- and FLC-resistant strains, respectively) of C. albicans. O.D. 560, optical density at 560 nm. The growth curves were obtained by growing the strains at 37°C in liquid YNB medium. The cell volumes were calculated from SEM observations, as described in Materials and Methods. In panel B, parts A, B, and C indicate the strains CO23S, CO23RFK, and CO23RFLC, respectively, with corresponding cell volumes.
FIG. 2.
FIG. 2.
EM localization of MP constituents in freeze-substituted yeast cells of C. albicans strains CO23S (A), CO23RFK (B), and CO23RFLC (C) following postembedding labeling with the MAb AF1 followed by gold-labeled secondary antibody. For technical details, see the text.
FIG. 3.
FIG. 3.
Experimental pathogenicity of C. albicans strains in systemic (A) and mucosal (B) infection models. (A) Male BALB/c mice were infected intravenously with the indicated C. albicans strains (inoculum size, 107 cells). Survival was determined over the time indicated. There was a statistically significant difference (P < 0.01) between the parental and each of the two drug-resistant strains. For further details, see Materials and Methods. (B) Oophorectomized, estrogen-treated rats were infected intravaginally with the indicated C. albicans strains (inoculum size, 107 cells). At the indicated time intervals, the intravaginal burden of fungal cells was measured as described in Materials and Methods. No statistically significant differences were found among the strains.
FIG. 4.
FIG. 4.
Hyphae and invasive hyphal growth of C. albicans strains CO23S, CO23RFK, and CO23RFLC. (A) Cells were induced to form hyphae by 24-h incubation at 37°C in YNB medium containing 0.1% (wt/vol) N-acetyl-d-glucosamine (line 1) or RPMI 1640 medium containing 10% fetal calf medium (line 2). Photomicrographs were taken with a phase contrast microscope using a 40× objective and are representative of 50% random fields observed. (B) Cells (104) of CO23S, CO23RFK, and CO23RFLC strains were suspended in 1 μl of YPD broth and spotted onto the surface of 4% serum plates containing 0.8 to 3% agar, and the plates were incubated at 37°C. Line 1, top view of spot colonies at 7 days of incubation on 0.8% agar using a 10× objective. Line 2, images of spot colony edges at 7 days of incubation on 3% agar using a 40× objective. The photographs are representative of the whole-mounted microscopic plates.
FIG. 5.
FIG. 5.
Adherence, biofilm, and XTT assay of C. albicans strains CO23S, CO23RFK, and CO23RFLC. (A) Percentage of plastic adherent cells of the strains CO23S, CO23RFK, and CO23RFLC. The cells were allowed to adhere to the polystyrene surface, and then 1 ml of Sabouraud dextrose agar, which was allowed to solidify, was poured onto the cells, and the mixture was incubated at 37°C for 24 h. (B) Production of biofilm on polystyrene surfaces. Biofilms were stained with crystal violet and photographed at 10× and 40× magnifications using an inverted microscope. (C) Equal numbers of cells from CO23S, CO23RFK, and CO23RFLC were suspended in 1 ml of RPMI medium and incubated in 12-well plates for the times indicated. Nonadherent cells were then removed by washing, and adherent cells were XTT assayed. Experiments were repeated three times with similar results.

Similar articles

Cited by

References

    1. Angiolella, L., B. Maras, A. R. Stringaro, G. Arancia, F. Mondello, A. Girolamo, A. T. Palamara, and A. Cassone. 2005. Glucan-associated protein modulations and ultrastructural changes of the cell wall in Candida albicans treated with micafungin, a water-soluble, lipopeptide antimycotic. J. Chemother. 17:409-416. - PubMed
    1. Balashov, S. V., S. Park, and D. S. Perlin. 2006. Assessing resistance to the echinocandin antifungal drug caspofungin in Candida albicans by profiling mutations in FSK1. Antimicrob. Agents Chemother. 50:2058-2063. - PMC - PubMed
    1. Bastert, J., M. Schaller, H. C. Korting, and E. G. V. Evans. 2001. Current and future approaches to antimycotic treatment in the era of resistant fungi and immunocompromised hosts. Int. J. Antimicrob. Agents 17:81-89. - PubMed
    1. Calabrese, D., J. Bille, and D. Sanglard. 2000. A novel multidrug efflux transporter gene of the major facilitator superfamily from Candida albicans (FLU1) conferring resistance to fluconazole. Microbiology 146:2743-2754. - PubMed
    1. Calderone, R. A., and P. C. Braun. 1991. Adherence and receptor relationships of Candida albicans. Microbiol. Res. 55:1-20. - PMC - PubMed

MeSH terms